Clearstead Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $39.7K | Hold |
633
| – | – | ﹤0.01% | 1355 |
|
2025
Q1 | $38.1K | Hold |
633
| – | – | ﹤0.01% | 1242 |
|
2024
Q4 | $36.9K | Hold |
633
| – | – | ﹤0.01% | 1231 |
|
2024
Q3 | $37.5K | Hold |
633
| – | – | ﹤0.01% | 1267 |
|
2024
Q2 | $35.5K | Sell |
633
-201
| -24% | -$11.3K | ﹤0.01% | 1245 |
|
2024
Q1 | $46.2K | Buy |
834
+201
| +32% | +$11.1K | ﹤0.01% | 781 |
|
2023
Q4 | $34.2K | Sell |
633
-733
| -54% | -$39.6K | ﹤0.01% | 832 |
|
2023
Q3 | $66.3K | Sell |
1,366
-427
| -24% | -$20.7K | ﹤0.01% | 829 |
|
2023
Q2 | $101K | Sell |
1,793
-1,057
| -37% | -$59.7K | 0.01% | 575 |
|
2023
Q1 | $154K | Buy |
2,850
+163
| +6% | +$8.8K | 0.01% | 434 |
|
2022
Q4 | $141K | Sell |
2,687
-59
| -2% | -$3.1K | 0.01% | 427 |
|
2022
Q3 | $130K | Buy |
2,746
+3
| +0.1% | +$142 | 0.01% | 421 |
|
2022
Q2 | $138K | Sell |
2,743
-2,973
| -52% | -$150K | 0.01% | 435 |
|
2022
Q1 | $348K | Buy |
5,716
+1,052
| +23% | +$64K | 0.02% | 319 |
|
2021
Q4 | $307K | Buy |
4,664
+4
| +0.1% | +$263 | 0.02% | 321 |
|
2021
Q3 | $293K | Buy |
4,660
+1,630
| +54% | +$102K | 0.02% | 312 |
|
2021
Q2 | $182K | Buy |
3,030
+6
| +0.2% | +$360 | 0.01% | 359 |
|
2021
Q1 | $167K | Hold |
3,024
| – | – | 0.01% | 357 |
|
2020
Q4 | $165K | Hold |
3,024
| – | – | 0.02% | 344 |
|
2020
Q3 | $151K | Buy |
+3,024
| New | +$151K | 0.02% | 313 |
|